Compositions and methods for producing il-16
CA3327908A1Undetermined Publication Date: 2025-10-23IMMUNITYBIO INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CA3327908
- Authority / Receiving Office
- CA · CA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-04-17
- Filing Date
- 2025-04-17
- Publication Date
- 2025-10-23
Abstract
An NK cell lysate is provided herein that includes a salt solution, a cytotoxic protein, and IL-16 endogenously produced by NK cells. Also provided is a composition including the NK cell lysate and optionally NK cell exosomes. A method of preparing the NK cell lysate and composition is provided herein, including lysing the NK cells to produce a lysate and removing intact NK cells, NK cell debris, and NK cell genomic DNA from the lysate, as well as a method for generating IL-16 from NK cells. Also provided herein are methods for stimulating an immune response, preventing, reducing the occurrence of, and / or treating an infection; preventing, reducing the occurrence of, and / or treating cancer; and initiating, enhancing, or prolonging an anti-tumor response. Also provided is a combination therapy including administering the NK cell lysate or composition and a therapeutically active agent, and a vaccine including the NK cell lysate or composition.
Need to check novelty before this filing date? Find Prior Art
